🔎 Trials Near Me

Utama › Dos Berlebihan Opioid › Massachusetts

Kajian klinikal Dos Berlebihan Opioid di Massachusetts

16 kajian untuk Dos Berlebihan Opioid sedang mencari peserta di lokasi di Massachusetts.

Bandar di Massachusetts

Teks kajian rasmi (Bahasa Inggeris)

Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents

  • Office-Based Addiction Treatment (OBAT) Clinic, BMC, Boston
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06732596

A Study of Brenipatide in Participants With Opioid Use Disorder

  • Brigham and Women's Hospital, Boston
  • Adams Clinical Boston, Boston
  • Boston Medical Center, Boston
  • dan 1 lagi
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07420283

Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.

  • Officed Based Addiction Treatment Program, Boston Medical Center, Boston
Mengambil pesertaFasa 4
Umur 18 hingga 99 · Semua jantina · Dikemas kini 14 Sep 2026 · NCT06323824

GLP-1R Agonist Treatment for Opioid Use Disorder

  • Stanley Street Treatment and Resources, Fall River
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 28 Ogo 2026 · NCT06548490

Assessing Optimal XRB Initiation Points in Jail

  • Tufts University Health Sciences, Boston
  • Baystate Health, Springfield
Mengambil pesertaFasa 4
Semua umur · Lelaki · Dikemas kini 7 Ogo 2026 · NCT06051890

Psilocybin in Cancer Pain Study

  • Dana-Farber Cancer Institute, Boston
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Ogo 2026 · NCT06001749

Impact of Federal and State Medications for Opioid Use Disorder (MOUD) Policy Changes During the Pandemic

  • VA Medical Center, Boston
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Jul 2026 · NCT07232641

A Brief Values Intervention to Support Veterans in Early Buprenorphine Treatment

  • VA Bedford HealthCare System, Bedford, MA, Bedford
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Jun 2026 · NCT05189223

Supporting Treatment Access and Recovery in COD

  • Behavioral Health Network, Holyoke
  • Behavioral Health Network, Orange
  • Behavioral Health Network, Springfield
  • dan 2 lagi
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Jun 2026 · NCT05138614

CARES (Comprehensive Analgesic, Recovery, and Education Support) for Surgery Trial

  • Harvard University- Brigham and Women's Hospital, Boston
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 6 Mei 2026 · NCT06027099

PrEP and MOUD Rapid Access for Persons Who Inject Drugs: The CHORUS+ Study

  • Boston Medical Center Faster Paths Bridge Clinic, Boston
  • Victory Programs Mobile Prevention Services Van and Navigation Center, Boston
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Apr 2026 · NCT05769218

Adolescent Outcomes of Post-operative Opioid EXposure

  • Boston Childrens Hopsital - Division of Addiction Medicine, Boston
Mengambil pesertaKajian pemerhatian
Umur 12 hingga 17 · Semua jantina · Dikemas kini 18 Mac 2026 · NCT06350409

Optimization of NIBS for Treatment of Addiction

  • Spaulding Rehabilitation Hospital - 5th Floor - Neuromodulation Center, Cambridge
Mengambil peserta
Umur 18 hingga 85 · Semua jantina · Dikemas kini 4 Mac 2026 · NCT04379115

Sensory Outcomes in Active Substance Users

  • Boston Medical Center/Boston University Medical Campus, Boston
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Feb 2026 · NCT06639438

Towards Testing the Effectiveness of Recovery Community Centers (RCCs)

  • Massachusetts General Hospital, Boston
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 26 Sep 2025 · NCT07010978

Semaglutide for Helping Opioid Recovery

  • Brigham and Women's Hospital, Boston
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 26 Sep 2025 · NCT06639464

Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.